Sanofi faces US class action over MS drug Lemtrada

A US law firm is launching a class action against France`s Sanofi over what it calls misleading statements on the safety and efficacy of its multiple sclerosis drug Lemtrada.

New data backs promise of long-acting Sanofi insulin

An improved version of Sanofi`s diabetes drug Lantus is better than the old one at controlling blood sugar levels and comes with fewer hypoglycemic events, new late-stage trial data showed on Tuesday.

Sanofi launches new antimalarial drug

The pharmaceutical company Sanofi has launched the large-scale production of a partially synthetic version of artemisinin.

Sanofi launches re-usable insulin pen

Sanofi India Ltd today announced the launch of AllStar, its first indigenously manufactured reusable insulin pen.

Soon, vaccine to prevent dengue infection

French pharmaceutical company Sanofi is conducting a key trial to prevent an estimated 100 million cases of dengue infection each year.

Sanofi to test Parkinson`s drug with Michael J. Fox Foundation

French drugmaker Sanofi said on Thursday it would collaborate with the Michael J. Fox Foundation to test an early- stage experimental treatment for Parkinson`s disease.